Assessing the efficacy of CIVID-19 vaccination: A critical analysis of the impact of COVID-19 vaccination on the risk of developing long-COVID and existing long-term symptoms' systematic review by Notarte et al. (2022)

Abstract Background: Long COVID has emerged as a significant public health concern, with vaccination playing a potential role in prevention and symptom management. Objective: This critical analysis examines Notarte et al.'s (2022) systematic review investigating the impact of COVID-19 vaccination on both developing long-term COVID and managing existing symptoms. Methods: The study followed for Systematic Reviews and the Preferred Reporting Items Meta-Analyses guidelines, utilising comprehensive database searches and the Newcastle-Ottawa Scale for quality assessment. From the 2,584 articles, 17 studies were selected, analysing over 17 million vaccinated individuals and 37,000 post-infection vaccination participants. Results: The review demonstrated that vaccination significantly reduced long COVID risk post-infection, with two-dose regimens showing greater efficacy than single-dose regimens. The effects on pre-existing long COVID symptoms varied across studies, ranging from improvement to no change or deterioration. Conclusion: While Notarte et al.'s review provides valuable insights into the role of vaccination in long-term COVID prevention and management, limitations including inconsistent definitions and limited data on boosters highlight the need for standardised definitions and more robust longitudinal studies. These findings have important implications for public health vaccination. Objective The study by Notarte et al. (2022) titled “Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review” The study scrutinised the effectiveness of the COVID vaccination. I am going to critically analyse this article and review the introduction, methodology, results, relevant policies, and future directions. This will shed light on the epidemiological characteristics of vaccination and COVID-19 outcomes. Research question: What are the consequences of COVID-19 vaccination on the emerging COVID-19 infection or long-term COVID-19, and how does it influence the intensity and duration of pre-existing long-COVID syndrome? Keywords: Long COVID, COVID-19 vaccination, systematic review analysis, vaccine efficacy, post-acute COVID-19 syndrome, public health policy Ethical Compliance: This critical analysis of a published systematic review did not require ethical approval, as it did not involve human subjects or primary data collection. Author Contributions: Anuradha Peduruhewa conceptualised the study design, conducted the critical analysis, wrote the manuscript, and approved the final version. Plain Language Summary This study reviews the research on how COVID-19 vaccines affect the long-term COVID symptoms. It analysed a major research paper by Notarte and colleagues that looked at two key questions: Can vaccines prevent long COVID? Do vaccines help people with long-term COVID symptoms? The research found that vaccination, especially with two doses, can reduce the risk of developing long-term COVID after infection. However, the effect of vaccines on existing long-term COVID symptoms varied; some people got better, others stayed the same, and some felt worse. While this research provides important information about the use of vaccines to prevent and treat long COVID, more long-term studies are needed. This understanding will help healthcare providers and policymakers make better decisions about vaccine programs and support people with a long COVID. Introduction According to the World Health Organization (WHO) definition, symptoms appear within three months of initial infection with COVID-19 and last for a minimum of two months, and this is not related to any other underlying condition. COVID-19 immunisation prevents the covid infection by eradicating the remaining virus reservoirs and restoring the regular immune response. (NIHR, 2024) COVID-19 immunisation provides a control, predictable, and protective vaccine-based immunity over to SARS-CoV-2 virus, it can be boosted by natural immunity which can be from previous infections also called ‘hybrid immunity.’ (Tylicki, 2023) Multiple studies suggest that the COVID-19 vaccine has an impact on developing long-COVID, by a 50 to 75% reduction. However, the available evidence is limited and conflicting. (University of Oxford, 2024) Post-acute sequelae of the SARS-CoV-2 infection are also known as long-covid. Individuals with constant or new symptoms extend beyond the acute state of COVID-19 infection. (Notarte et al., 2022) Some studies show that patients with long-COVID are frequently older, probably female, and they need hospital admission and further clinical and medical treatment and assessment of the condition. (Sudre et al., 2020) According to the Notarte article explores the possible influence of COVID-19 vaccination on the risk of acquiring long-COVID symptoms, how vaccination may influence the prevalence of subsisting long-COVID symptoms, and the association between immunisation and COVID-19 infection, which is vital for understanding the long-term consequences of COVID-19 infection and the potential benefit of vaccination in alleviating these effects. Multiple studies have provided valuable insights into the persuasiveness of vaccination in preventing COVID-19 infection and its associated complications. For example, the study of the BNT 16262 mRNA COVID-19 vaccine in a mass immunisation setting-imposed outcomes such as hospitalisation, severe illness, and death. (Dagan et al., 2021) In this paper Notarte addresses the effect of the COVID-19 vaccine on both the likelihood of contracting the virus and the severity of its symptoms. Persistent symptoms affect several organ systems including the respiratory, cardiovascular, neurological, and psychological systems. Many people who recover from an acute infection are at risk for this serious health condition. To address the long-term health implications of COVID-19 knowledge of, the nature, frequency, and etiology are crucial. Research has examined the association between physiological and immunological aspects and emphasised the mechanism of these persistent symptoms of COVID-19 infection. (Osiaevi et al., 2022; De Jong et al.,2023) Some studies have focused on the subtype and clinical clusters of long-covid delivering an understanding of the heterogeneity of symptoms and manifestation followed in person with long-term COVID-19 effects. (Magnusson et al.,2022; Reese et al.,2022) This study emphasises the significance of understanding the correlation between COVID-19 immunisation and long-term COVID-19, as it may provide valuable insights for public health measures and enhance results. It analyzes the role of vaccination in reducing the risk of severe outcomes such as hospital admission or death, as well as its impact on an individual’s general health. (Notarte et al., 2022) Assessing the efficacy of COVID-19 immunisation in avoiding extended COVID is vital for public health since it has a substantial influence on people’s well-being and quality of life. Gaining a comprehensive understanding of the effectiveness of the vaccine is crucial for minimising the potential long-term health impact and alleviating strain on the health system. (Simon et al., 2021) To establish public trust and confidence in immunisation initiatives vaccination effectiveness must be evaluated. Studies on vaccine appropriateness and efficacy may address concerns, debunk disinformation, and enhance vaccination uptake rates, thereby curbing the spread of the virus and minimising long-term health consequences. (Pogue et al., 2020) Methodology A systematic review is a rigorous study that seeks to address a particular research issue by comprehensively assessing all relevant papers on a given subject, using transparent and replicable methodologies. (Turney, 2022) To investigate the impact of immunisation on the risk of developing long-COVID and existing long-COVID symptoms, this article uses a systematic review of related studies as a methodology (Notarte et al., 2022) An observational cohort study with a prospective design used to investigate the covariates among subjects who were received different vaccines and utilise a binary logistic regression model to decide the association among vaccination factors and its outcomes. (Ayoubkhani et al., 2022) A prospective observational study was used to evaluate the COVID-19 immunisation on the health, symptoms, and immunological responses of individuals with protracted COVID-19 symptoms. Questionnaires, immunophenotyping tests, and statistical analyses were used for this evaluation. (Grady et al., 2024) The Epidemiological approach to this study selection of the affected population based on vaccinated or non-vaccinated individuals, COVID-19 survivors, individuals with long-term symptoms and the general population have been considered. (Davis et al., 2023) Search strategy and selection criteria Sponsors maintain ethical values, scientific integrity, and openness in clinical trials. (NHS Health Research Authority, 2024) From data collection to publication clearance, the researchers handled everything without sponsor involvement. The database searches, publication elimination relevance assessments, duplication elimination, and methodological rigor assessments were rigorous. Authors, country, sample size. Vaccination status, vaccine type, and clinical data, mostly on COVID-19 symptoms before and after immunisation, were also collected. (Notarte et al., 2022) The PRISMA statement guidelines improve systematic review and meta-analysis documentation in healthcare searches. The 27-item checklist and flow diagram include the title, abstract, introduction, methodology, results, discussion, and funding sources. Transparency and potential improve research quality and dependability. (Liberati et al., 2009) English-language human studies literature is reviewed using Boolean operation. The Population, Interventi

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.